FDA issues non-approvable letter for Revelation Tx.

Detalles Bibliográficos
Publicado en:Medical Letter on the CDC pp. 15 - 16
Formato: brief item Journal Article
Publicado: NewsRx 2004 Jul 4
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106637035&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 106637035
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10782907
        7CM
      jtl: Medical Letter on the CDC
      issn: 10782907
      maglogo: N
    pubinfo:
      dt: 2004 Jul 4
      pid: 8899
      pub: NewsRx
      place: New Haven, Connecticut
    artinfo:
      ui:
        106637035
        106637035
        2005084350
        106637035
      ppf: 15
      ppct: 1
      formats:
      tig:
        atl: FDA issues non-approvable letter for Revelation Tx.
      aug:
      sug:
        subj:
          Atrial Fibrillation Therapy
          Catheter Ablation
          Consumer Product Safety
          Product Development
          Device Approval
          United States Food and Drug Administration
      pubtype: Periodical
      doctype:
        brief item
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N